Top Industry Leaders in the Legg-Calve-Perthes Disease Market
Latest Legg-Calve-Perthes Disease Treatment Companies Updates
Nanoscope Labs: Their nanoScan imaging technology is being investigated for early detection and monitoring of LCPD, offering potential for improved diagnosis and treatment planning.
Orthofix Medical Inc.: Their Exogen bone growth stimulator received FDA clearance for LCPD treatment, providing a non-surgical option for some patients.
Stryker Corporation: Their Physio-Control iRICE System for joint immobilization is gaining traction in LCPD management due to its ease of use and patient comfort.
Smith & Nephew PLC: Their ExacTech Ncompass hip implant system offers minimally invasive surgery options for LCPD patients, potentially leading to faster recovery times.
Hospital for Special Surgery and Boston Children's Hospital: Collaborating on a research project to develop a machine learning model to predict the severity and outcome of LCPD, aiming to personalize treatment plans.
List of Legg-Calve-Perthes Disease Treatment companies in the market:
- BASF
- Sunline
- IOLCP
- Shandong Xinhua Pharmaceutical Co. Ltd
- Dr. Reddy's
- DePuy Synthes
- Prime Medical
- Zimmer
- Biomet Holdings, Inc.
- 3M Healthcare
- Össur Hf
- DJO
- Stryker Corporation.
